Striving to make the incurable,curable
Immetacyte, leading the T-Cell therapy revolution
We're developing this truly personalised TIL therapy in a range of cancer indications, by improving and streamlining the process.
We're a clinical-stage immuno-oncology company with an established, profitable GMP CDMO business for advanced cell therapies.Read More
News & Events
All the very latest developments from our team.